Bridge Biotherapeutics Inc - ESG Rating & Company Profile powered by AI
This webpage of Bridge Biotherapeutics Inc was prepared by All Street Sevva using advanced machine learning. Jump to the end of this page for potential risks for Bridge Biotherapeutics Inc based on sector, geography and size. Alternative companies in the scoring industry group for Bridge Biotherapeutics Inc are shown.
Bridge Biotherapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.3; made up of an environmental score of 0.0, social score of 2.7 and governance score of 1.1.
1.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 2416 | Waverley Pharma Inc | 1.4 | Low |
| 2416 | XBiotech Inc | 1.4 | Low |
| 2454 | Bridge Biotherapeutics Inc | 1.3 | Low |
| 2454 | Ambee Pharmaceuticals Ltd | 1.3 | Low |
| 2454 | Aslan Pharmaceuticals Ltd | 1.3 | Low |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Bridge Biotherapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc offer flexible work?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Bridge Biotherapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Bridge Biotherapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Bridge Biotherapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Bridge Biotherapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Bridge Biotherapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Bridge Biotherapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Bridge Biotherapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Bridge Biotherapeutics, Inc., a clinical stage biotech company, engages in the development of therapeutics for the treatment of ulcerative colitis, fibrotic diseases, and cancers worldwide. Its products in pipeline includes BBT-401, a Pellino-1 inhibitor, which is in Phase I clinical trial for the treatment of ulcerative colitis; and BBT-877, an autotaxin inhibitor that is in Phase I clinical trial for the treatment of various fibrotic diseases, such as idiopathic pulmonary fibrosis. Bridge Biotherapeutics, Inc. has a research collaboration with Atomwise to launch small molecule programs across various therapeutic areas using structure-based AI technology for drug discovery. The company was founded in 2015 and is headquartered in Seongnam, Korea.